Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.590
-0.135 (-3.62%)
Apr 7, 2026, 8:54 AM EDT - Market open
Evaxion Employees
Evaxion had 46 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
46
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$163,652
Profits / Employee
-$167,543
Market Cap
29.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 46 | 0 | - |
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Dec 31, 2023 | 49 | -14 | -22.22% |
| Dec 31, 2022 | 63 | 2 | 3.28% |
| Dec 31, 2021 | 61 | 26 | 74.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Longeveron | 38 |
| Palatin Technologies | 29 |
| Actinium Pharmaceuticals | 25 |
| INmune Bio | 21 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Hyperion DeFi | 14 |
EVAX News
- 8 days ago - Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress - GlobeNewsWire
- 19 days ago - Notice to convene Evaxion's Annual General Meeting - GlobeNewsWire
- 4 weeks ago - Evaxion announces business update and full year 2025 financial results - GlobeNewsWire
- 4 weeks ago - Evaxion plans to file 2025 annual report later today - GlobeNewsWire
- 5 weeks ago - Evaxion to announce business update and full year 2025 financial results on March 5, 2026 - GlobeNewsWire
- 3 months ago - Evaxion expands AI-Immunology™ platform into autoimmune diseases - GlobeNewsWire
- 3 months ago - Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week - GlobeNewsWire
- 3 months ago - Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Benzinga